CN102552995A - Personal lubricant - Google Patents
Personal lubricant Download PDFInfo
- Publication number
- CN102552995A CN102552995A CN2010105919550A CN201010591955A CN102552995A CN 102552995 A CN102552995 A CN 102552995A CN 2010105919550 A CN2010105919550 A CN 2010105919550A CN 201010591955 A CN201010591955 A CN 201010591955A CN 102552995 A CN102552995 A CN 102552995A
- Authority
- CN
- China
- Prior art keywords
- human body
- body lubricants
- active compound
- extract
- vasodilator active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a personal lubricant which comprises a vasodilator active compound. The personal lubricant applies the vasodilator active compound to the lubrication in terms of sexual life, not only can help a penis to sufficiently erect and prevent premature ejaculation, but also ensures that a vagina/labia is engorged and a clitoris is sufficiently erected, and promotes the vaginal discharge to be increased, can also protect and moisten the vagina and repair the vaginal mucosa, and achieves multiple purposes.
Description
Technical field
The present invention relates to human body lubricants, a kind of human body lubricants that can increase voluptus and help the erection effect specifically is provided.
Background technology
Existing human body lubricants has oily lubricant and water-based lubricant two big classes, and it does not increase female sexual pleasure and helps the erection effect.
And in actual life, along with involutional arrival, each organ of human body can be old and feeble gradually.Aspect sexual life, the male often shows as penis can not normal erection or erect not hardly, and the women then shows as diseases such as vaginal dryness, libido be low.The particularly increase of the deterioration of local environment and stress, above symptom are very general and the impetus of growth year by year arranged in the adult.
Therefore, a kind of human body lubricants that can effectively improve adult's life quality being provided is market institute urgent needs.
Summary of the invention
The objective of the invention is in order to overcome the deficiency of above-mentioned human body lubricants, a kind of human body lubricants that can increase women's pleasant sensation and male penis erection effectively is provided.
The present invention realizes through following technical scheme:
A kind of human body lubricants, it includes vasodilator active compound.
Described human body lubricants includes vasodilator active compound and matter acid sodium.
Said vasodilator active compound comprises nitrate, peptide, antihypertensive, long-acting and fugitive α-adrenergic receptor blocker, prostaglandin and phosphodiesterase inhibitor.
Described human body lubricants also includes Herba Epimedii extract, Radix Puerariae extract puerarin, Herba Trifolii Pratentis extract, Radix Angelicae Sinensis extract, beans extract, interferon, benzene and pricks in bromine sodium, Galla Chinensis extract, the matrine one or more.
Described human body lubricants also contains interferon.
Described human body lubricants also includes dermal osmosis accelerator.
Human body lubricants is buffered to PH3.5-5.
Contain the application of vasodilator active compound in human body lubricants and condom lubricant.
Contain the application in human body lubricants and condom lubricant of vasodilator active compound and hyaluronate sodium.
Vasodilator active compound among the present invention; Can effective stimulus with increase the blood flow in cavernous body of penis, vagina, labia, the cavernous body of clitoris and promote its hyperemia; Thereby penis, clitoris are fully erected, and alleviating masculinity and femininity can't sexual intercourse or be difficult to reach orgastic symptom.Simultaneously, the vasodilator active compound among the present invention can also effectively promote the increase of vaginal secretions, for sexual intercourse good channel environment is provided smoothly.
As for the above-mentioned effect and the mechanism of action of vasodilator active compound, confirmed by the modern medicine Institute of Science already, no longer repeat to discuss here.
Need to prove that especially the matter acid sodium among the present invention, has special physiological properties at natural being present in the tissue:
1, intelligent moisture-keeping function: matter acid sodium is described as nature moisturizing factor, and the carboxyl in its molecule can form hydrogen bond and combine a large amount of water with other polar groups with water.Can also regulate water absorption automatically according to the humidity of environment, make vagina remain optimum humidity, this is that common wetting agent is incomparable.
2, improve the vagina skin quality: matter acid sodium is coated with into the skin of vulva mucous membrane surface, can form one deck viscous transparent hydration shell, effectively stops water loss, and part matter acid sodium can also be penetrated into skin corium, regulates water absorption, can make vagina remain optimum humidity.
3, adhesion-promoting effect: matter acid sodium is the macromolecule mucopolysaccharide, also can show good adhesion-promoting effect even content is low, the efficient effect that above-mentioned vasodilator active compound performance is used.
4, bio-adhesive effect: matter acid sodium can stick with vaginal mucosa, and the protection vaginal mucosa is injury-free.
5, reparation and promoting healing effect: matter acid sodium is that wound does not have the indispensable material of cicatrix reparation, can effectively suppress colpitis here, repairs vaginal mucosa.
6, slow releasing function: matter acid sodium molecule is just as a dynamic molecular sieve, and medicine can be embedded in the cancellated macromole of matter acid sodium through covalent, is attached to vagina surface for a long time together with medicine, promotes the utilization and the absorption of medicine.
Therefore; Matter acid sodium and vasodilator active compound are applied to the lubricated of sexual life aspect; Not only can help penis fully to erect, prevent premature ejaculation; Can make again that vagina/labia is congested, clitoris fully erects and promotes vaginal secretions to increase, more can protect vagina, moisten vagina and repair vaginal mucosa, in fact good recipe for achieving many things at one stroke.
Have medicines such as the plant extract of androgen-like action, plant extract, antibacterial-anti-inflammatory drug and in above-mentioned prescription, add again, then can further enrich the function of human body lubricants of the present invention with estrogen-like effects.
Multifunctional human lubricant of the present invention during use, is coated on it on penis, vaginal orifice or the condom, directly brings medicine into intravaginal by penis/condom vagina is carried out maintenance and treatment.
The specific embodiment
Below in conjunction with specific embodiment the present invention is described further:
Embodiment 1:
In 100 milliliters of human body lubricants, PGE1 0.1 gram, glycerol 15 grams, hyaluronate sodium 0.5 gram, purified water surplus.
Embodiment 2:
In 100 milliliters of human body lubricants, PGE1 0.5 gram, hyaluronate sodium 0.15 gram, sodium oxide 0.5 gram, Borax 0.05 gram, ethyl hydroxybenzoate 0.03 gram, purified water surplus.
Embodiment 3:
In 100 milliliters of human body lubricants, PGE1 0.15 gram, hyaluronate sodium 0.5 gram, Herba Epimedii extract 0.05 gram, Radix Puerariae extract puerarin 0.1 gram, Galla Chinensis extract 0.05 gram, sodium oxide 0.5 gram, Borax 0.05 gram, ethyl hydroxybenzoate 0.03 gram, purified water surplus.
Claims (10)
1. human body lubricants, it contains vasodilator active compound.
2. human body lubricants according to claim 1, it contains vasodilator active compound and matter acid sodium.
3. human body lubricants according to claim 1 and 2; It is characterized in that said vasodilator active compound comprises nitrate, peptide, antihypertensive, long-acting and fugitive α-adrenergic receptor blocker, prostaglandin and phosphodiesterase inhibitor.
4. human body lubricants according to claim 1 and 2; It is characterized in that, also include Herba Epimedii extract, Radix Puerariae extract puerarin, Herba Trifolii Pratentis extract, Radix Angelicae Sinensis extract, beans extract, interferon, benzene and prick in bromine sodium, Galla Chinensis extract, the matrine one or more.
5. human body lubricants according to claim 1 and 2 is characterized in that, also contains interferon.
6. human body lubricants according to claim 1 and 2 is characterized in that, also contains dermal osmosis accelerator.
7. human body lubricants according to claim 1 and 2 is characterized in that, human body lubricants is buffered to PH3.5-5.
8. contain the application of vasodilator active compound in human body lubricants and condom lubricant.
9. contain the application in human body lubricants and condom lubricant of vasodilator active compound and hyaluronate sodium.
10. one kind like claim 8 or 9 described human body lubricants; It is characterized in that said vasodilator active compound is one or more in nitrate, peptide, antihypertensive, long-acting and fugitive α-adrenergic receptor blocker, prostaglandin, the phosphodiesterase inhibitor.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105919550A CN102552995A (en) | 2010-12-07 | 2010-12-07 | Personal lubricant |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105919550A CN102552995A (en) | 2010-12-07 | 2010-12-07 | Personal lubricant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102552995A true CN102552995A (en) | 2012-07-11 |
Family
ID=46400440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105919550A Pending CN102552995A (en) | 2010-12-07 | 2010-12-07 | Personal lubricant |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102552995A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103405594A (en) * | 2013-05-30 | 2013-11-27 | 石杰克 | Water-soluble personal lubricant, preparation method thereof, and condom employing lubricant |
| CN109700897A (en) * | 2019-02-14 | 2019-05-03 | 重庆市洲仨科技发展有限公司 | A kind of female health external application Essence |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000060939A1 (en) * | 1999-04-13 | 2000-10-19 | John Lezdey | Lubrication composition |
| CN1498096A (en) * | 2001-03-30 | 2004-05-19 | ��ͼ��ҽҩ��չ����˾ | Condom with erectogenic composition |
| CN1655740A (en) * | 2002-04-16 | 2005-08-17 | 富图拉医药发展有限公司 | Condom |
| WO2006127057A1 (en) * | 2005-05-24 | 2006-11-30 | Lyle Corporate Drvelopment, Inc. | Non-systematic vaginal administration of estrogen and an androgen for the treatment of sexual dysfunction |
| CN101422461A (en) * | 2007-12-11 | 2009-05-06 | 北京琥珀光华医药科技开发有限公司 | Preparation method of matrine vagina effervescence tablet and use thereof |
| CN101720223A (en) * | 2007-07-03 | 2010-06-02 | 因德纳有限公司 | Combinations of vasoactive substances with estrogens and their use in the treatment of female sexual dysfunctions |
| CN101773513A (en) * | 2009-01-14 | 2010-07-14 | 邢建慧 | Water soluble body lubricant with natural antibacterial components and with pH value consistence with pH value of vagina |
-
2010
- 2010-12-07 CN CN2010105919550A patent/CN102552995A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000060939A1 (en) * | 1999-04-13 | 2000-10-19 | John Lezdey | Lubrication composition |
| CN1498096A (en) * | 2001-03-30 | 2004-05-19 | ��ͼ��ҽҩ��չ����˾ | Condom with erectogenic composition |
| CN1655740A (en) * | 2002-04-16 | 2005-08-17 | 富图拉医药发展有限公司 | Condom |
| WO2006127057A1 (en) * | 2005-05-24 | 2006-11-30 | Lyle Corporate Drvelopment, Inc. | Non-systematic vaginal administration of estrogen and an androgen for the treatment of sexual dysfunction |
| CN101720223A (en) * | 2007-07-03 | 2010-06-02 | 因德纳有限公司 | Combinations of vasoactive substances with estrogens and their use in the treatment of female sexual dysfunctions |
| CN101422461A (en) * | 2007-12-11 | 2009-05-06 | 北京琥珀光华医药科技开发有限公司 | Preparation method of matrine vagina effervescence tablet and use thereof |
| CN101773513A (en) * | 2009-01-14 | 2010-07-14 | 邢建慧 | Water soluble body lubricant with natural antibacterial components and with pH value consistence with pH value of vagina |
Non-Patent Citations (1)
| Title |
|---|
| HARIN PADMA-NATHAN ETAL.: ""Efficacy and Safety of Topical Alprostadil Cream for the Treatment of Female Sexual Arousal Disorder (FSAD): A Double-Blind, Multicenter, Randomized, and Placebo-Controlled Clinical Trial"", 《JOURNAL OF SEX & MARITAL THERAPY 》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103405594A (en) * | 2013-05-30 | 2013-11-27 | 石杰克 | Water-soluble personal lubricant, preparation method thereof, and condom employing lubricant |
| CN109700897A (en) * | 2019-02-14 | 2019-05-03 | 重庆市洲仨科技发展有限公司 | A kind of female health external application Essence |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20044699L (en) | Vaginal Care Composition | |
| HRP20161574T1 (en) | New medicines for topic use based on sulfated hyaluronic acid as activating or inhibiting agent of the cytokine activity | |
| EA200401355A1 (en) | APPLICATION OF CYCLOPAMINE IN THE TREATMENT OF PSORIASIS AND OTHER SKIN DISEASES | |
| WO2005112872A1 (en) | Peroxide compounds for the prevention and treatment of sexual dysfunction in humans | |
| CN102716511A (en) | Antibacterial and hypoallergenic spray | |
| CN110604810A (en) | Hydrolyzed collagen gel for gynecology and preparation method thereof | |
| CL2008002466A1 (en) | Anhydrous topical pharmaceutical composition comprising a vasodilator and an acceptable carrier; use of topical anhydrous composition on genital areas for improved sexual well-being. | |
| CN102552995A (en) | Personal lubricant | |
| MX2007013466A (en) | Cosmeceutical composition. | |
| JP5965393B2 (en) | Kit of parts for treating and / or preventing skin ulcers | |
| CN103316262A (en) | Gynecological external antibacterial liquid and preparation method thereof | |
| KR20140097095A (en) | Composition for promoting the volume of skin | |
| CN105056290B (en) | A kind of medical bio hydrogel functional dressings and preparation method thereof | |
| RU2372933C1 (en) | Medical product and medicinal composition for manufacturing thereof | |
| CN113616774A (en) | Plant stem cell-containing antibacterial composition, maintenance antibacterial liquid and preparation method thereof | |
| CN103877452B (en) | A kind of chitosan vaginal washing fluid and preparation method thereof | |
| CN1053829C (en) | Prepn of Chinese medicine for gynopathy | |
| US7563464B1 (en) | Treatment of mucosal membranes utilizing phytoestrogen | |
| CN111631991A (en) | Private nursing lotion | |
| CN103767900A (en) | Herbal feminine nursing washing lotion | |
| RU2262948C1 (en) | Method for treating candidosis vulvovaginitis in pregnant women | |
| CN2601025Y (en) | Health underpants | |
| CN105148137A (en) | Externally-applied Chinese herbal medicine for treating prostatic hyperplasia | |
| ES2472366A1 (en) | Cosmetic or pharmaceutical composition in the form of an aqueous gel containing hyaluronic acid for the treatment of dyspareunia (Machine-translation by Google Translate, not legally binding) | |
| CN115381925A (en) | Cervical repairing dressing and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120711 |